The Global Hypertrophic and Keloid Scar Treatment Market Size accounted for USD 6.8 Billion in 2021 and is projected to achieve a market size of USD 15.7 Billion by 2030 rising at a CAGR of 10% from 2022 to 2030. The market is driven by rising consciousness about the aesthetic appearance. Scar treatment delivers complete skin rejuvenation, therefore improving aesthetic appeal. The need for aesthetic products mostly exists among women, which are the major consumers of these products. Also, the increase in the numeral of road accidents and burn cases has also influenced the development of the hypertrophic and keloid scar treatment market.

Hypertrophic and Keloid Scar Treatment Market Report Statistics

• Global hypertrophic & keloid scar treatment market revenue is estimated to reach USD 15.7 Billion by 2030 with a CAGR of 10% from 2022 to 2030
• North America hypertrophic and keloid scar treatment market share accounted for over 35% shares in 2021
• According to the Colorado Springs Dermatology Clinic, acne affects roughly 40 to 50 million people annually in the U.S.
• Asia-Pacific hypertrophic and keloid scar treatment market growth will register swift CAGR from 2022 to 2030
• Based on scar type, keloid captures over 65% of the overall market share in 2021
• Among end-user, hospitals occupied more than 44% of the market share from 2022 to 2030
• Growth in availability of technologically advanced products is a popular hypertrophic and keloid scar treatment market trend that is fueling the industry demand

Global Hypertrophic and Keloid Scar Treatment Market Dynamics

Market Drivers

• Growing demand for aesthetic surgeries
• Rising number of road accidents and burn cases
• Increasing advantages of laser treatment
• Surging need of topical solutions

Market Restraints

• High cost of these treatments
• Lack of awareness among developing countries

Market Opportunities

• Increasing healthcare expenditure
• Growth in research & development activities

Hypertrophic and Keloid Scar Treatment Market Report Coverage

Market	Hypertrophic and Keloid Scar Treatment Market
Hypertrophic and Keloid Scar Treatment Market Size 2021	USD 6.8 Billion
Hypertrophic and Keloid Scar Treatment Market Forecast 2030	USD 15.7 Billion
Hypertrophic and Keloid Scar Treatment Market CAGR During 2022 - 2030	10%
Hypertrophic and Keloid Scar Treatment Market Analysis Period	2018 - 2030
Hypertrophic and Keloid Scar Treatment Market Base Year	2021
Hypertrophic and Keloid Scar Treatment Market Forecast Data	2022 - 2030
Segments Covered	By Scar Type, By Product, By End-User, And By Geography
Regional Scope	North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
Key Companies Profiled	Sonoma Pharmaceuticals, Inc., Lumenis Ltd., Suneva Medical, Inc., Alliance Pharma, PLC, Smith & Nephew PLC, Merz Pharmaceuticals, LLC, Mölnlycke Health Care AB, Newmedical Technology, Inc., Cynosure, Inc., Perrigo Company PLC, and Enaltus, LLC.
Report Coverage	Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Regulation Analysis

Hypertrophic and Keloid Scar Treatment Market Growth Factors

Increase in consciousness regarding esthetic appeal has led to the market development. As per Plastic Surgery Statistics Report, around 182,321 reconstructive processes for scar revision were performed in 2017. Henceforth, the need for reconstructive processes also plays a significant role in boost up the market development.

Hypertrophic and Keloid Scar Treatment Market Insights

Increase in burn injury cases has also led to augmented need for hypertrophic and keloid scar treatments. Plastic surgeries or resurfacing laser therapies are usually performed to eliminate these marks. Hypertrophic burn marks can affect a victim’s appearance and are related with other conditions, for instance, contractures and pruritis.

The introduction of technically advanced products, for instance, laser therapies, will also support industry growth. These products assistance reduce scars caused owing to trauma injuries, burns, and surgery. For example, Non-ablative laser therapy destroys scar tissues through vascularization with the aid of a pulsed dye laser. Though, exorbitant prices of laser products are expected to hamper the market development.

Hypertrophic and Keloid Scar Treatment Market Segmentation

The global hypertrophic and keloid scar treatment market is segmented based on scar type, product, end-user, and geography.

Hypertrophic and Keloid Scar Treatment Market By Scar Type

• Hypertrophic
• Keloid

According to the hypertrophic and keloid scar treatment industry analysis, keloid sub-segment generated the largest revenue in 2021 and is expected to do so in the coming years. Keloid scars can grow large and extend beyond the wound area. Furthermore, these scars are more difficult to heal and have a high recurrence rate. In addition to that, hypertrophic sub-segment is expected to attain a significant growth rate during the projected timeframe.

Hypertrophic and Keloid Scar Treatment Market By Product

• Topical Products
  • Silicone Sheets
  • Creams
  • Gels
  •  Others
• Laser Product
  • Pulse-Dyed
  • CO2
  • Others
• Injectable
• Others

As per hypertrophic and keloid scar treatment market forecast, the topical products sub-segment accounted for 41% market shares in 2021 and is expected to maintain this trend over the forecasted timeframe of 2022 to 2030. This dominance can be linked to the increased use of topical products on hypertrophic and keloid scars, such as lotions, silicone sheets, and gels. Because these topical medicines are easily accessible to clients as over-the-counter (OTC) items, they are often purchased.

Hypertrophic and Keloid Scar Treatment Market By End-User

• Hospitals
• Clinics
• Retail Pharmacies/E-commerce

Based on end-user, the hospitals segment will lead the market in 2021, controlling for more than 44% of total revenue. This can be attributed to an increase in hospital admissions as well as an increase in the number of hospitals worldwide. The retail pharmacies/e-commerce segment is expected to grow at the fastest rate over the forecast period. This can be credited to the nature of product availability.

Hypertrophic and Keloid Scar Treatment Market Regional Outlook

North America

• U.S.
• Canada

Europe

• U.K.
• Germany
• France
• Spain
• Rest of Europe

Asia-Pacific

• India
• Japan
• China
• Australia
• South Korea
• Rest of Asia-Pacific

Latin America

• Brazil
• Mexico
• Rest of Latin America

The Middle East & Africa

• South Africa
• GCC Countries
• Rest of the Middle East & Africa (ME&A)

Hypertrophic and Keloid Scar Treatment Market Regional Analysis

In 2021, North America captures the largest market share and is expected to observer steady growth during the forthcoming years. High prevalence of skin-related disorders, burn injuries, and trauma are among the main factors accountable for the market growth. Furthermore, accessibility and acceptance of progressive treatment options, for instance, laser treatments, are projected to support the development. Asia-Pacific is expected to observer the fastest CAGR over the forecast time frame due to obtainability of technically progressive products and occurrence of a large numeral of producers in nations, for instance, China. Accessibility of laser instruments at cheaper prices in developing countries has increased their acceptance, thus pushing market growth. Due to high incidence of burn injuries, India has also backed considerably to the region’s development.

Hypertrophic and Keloid Scar Treatment Market Players

Market companies are concentrating on implementing new strategies for instance regional expansion, partnerships, mergers and acquisitions, new product launches, and distribution agreements to surge their revenue share. The major players associated with the Hypertrophic & keloid scar treatment market are Sonoma Pharmaceuticals, Inc., Lumenis Ltd., Suneva Medical, Inc., Alliance Pharma, PLC, Smith & Nephew PLC, Merz Pharmaceuticals, LLC, Mölnlycke Health Care AB, Newmedical Technology, Inc., Cynosure, Inc., Perrigo Company PLC, and Enaltus, LLC.

TABLE OF CONTENT